Germany s vaccine committee has said AstraZeneca s Covid jab should only be given to people aged under 65.
German vaccine officials say there is not enough data about the efficacy of AstraZeneca s Covid jab for older people.
Photo: Verwendung weltweit/ AFP
The committee cited insufficient data over its efficacy for older people.
The European Medicines Agency is to decide on Friday whether to approve the vaccine for use across the EU.
The UK has been using the AstraZeneca vaccine in its mass immunisation programme for weeks now, and public health officials say it is safe and provides high levels of protection .
UK-based AstraZeneca has said production issues at its Europe-based plants mean it will be unable to deliver the promised number of doses to the bloc.
news
Germany facing 10 weeks of vaccine shortages
Germany is likely to face a shortage of coronavirus vaccines until at least April, the country s health minister has warned. We will still have at least 10 tough weeks with a shortage, Jens Spahn wrote on Twitter.
The pace of Germany s rollout has been criticised, and it has failed to meet its own daily target of vaccinations.
Mr Spahn s comments come amid a row between the EU and the vaccine maker AstraZeneca over supply shortages.
The UK-based company has said production issues at its Europe-based plants means it will be unable to deliver the promised number of doses to the 27-member bloc.
यूरोप का दोहरा मानदंड - Naya India nayaindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nayaindia.com Daily Mail and Mail on Sunday newspapers.
Covid: UK vaccine supplies won t be interrupted - Gove
Published
image copyrightPA Media
There will be no interruption to UK vaccine supplies, Cabinet Office minister Michael Gove has said, after the EU urged AstraZeneca to supply it with doses from UK plants. It is the case that the supplies that have been planned, paid for and scheduled should continue, he added.
The EU and AstraZeneca are involved in a row over vaccine supply shortages.
It cited a lack of sufficient data to recommend use in older age groups.
The EU has demanded that UK-made jabs are diverted to mainland Europe to fulfil contractual obligations.